INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,237 | -23.9% | 14,998 | -1.9% | 0.02% | -64.4% |
| Q2 2023 | $623,567 | +12.7% | 15,291 | +3.0% | 0.04% | +7.1% |
| Q1 2023 | $553,534 | +11.9% | 14,852 | +4.8% | 0.04% | +2.4% |
| Q4 2022 | $494,531 | -51.2% | 14,174 | -21.7% | 0.04% | -57.3% |
| Q3 2022 | $1,013,000 | +1.5% | 18,102 | -6.1% | 0.10% | +4.3% |
| Q2 2022 | $998,000 | -29.1% | 19,285 | -0.4% | 0.09% | -16.4% |
| Q1 2022 | $1,407,000 | -50.6% | 19,362 | -19.7% | 0.11% | -47.1% |
| Q4 2021 | $2,850,000 | – | 24,101 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |